News

Nicole B. Saphier, MD

“Dr. Saphier would be a catastrophic mistake on messaging and communicating with MAHA at a time where the coalition is very fragile,” one opponent says. 

Siemens Healthineers

The Erlangen, Germany-based device manufacturer announced its quarterly earnings results on May 7, which included a 6.5% year-over-year decline in revenue for its diagnostics segment. 

Thumbnail

First approved by the FDA in 2021, providers have rapidly adopted this clinical innovation, which offers greater accuracy in detecting prostate cancer. 

GLP-1 receptor agonists (GLP-1-RAs) have become the wonder drug not only of weight loss, but also for improving cardiovascular health in a growing number of positive cardiovascular trials. The latest study of more than 13,000 patients presented at Heart Rhythm 2026 this week showed the GLP-1 reduce atrial fibrillation (AFib) and survival, even after accounting for the drug’s impact on weight loss.

The agency said the new program, made possible by Medicare Part D, begins on July 1 and will extend until the end of 2027. For $50 a month, Medicare beneficiaries will be able to access popular weight loss drugs, in hopes they will improve overall health.

emergency department

The perception is probably more pronounced in community hospital EDs than their academic counterparts. 

Medical malpractice gavel diagnostic error mistake stethoscope

In a lawsuit, the daughters of a deceased patient accuse Alegent Health-Community Memorial Hospital of Missouri Valley of medical malpractice and negligence, alleging donations were harvested without proper consultation. It’s alleged that their father was not registered as an organ donor.

TerraPower breaks ground on world's largest isotope production facility

Leaders involved in the new facility’s development estimate it will increase global Ac-225 production capacity twentyfold. 

physician burnout

Physicians who walk away from medicine before reaching their 25th year of practice tend to quit mainly due to the stress and hassles of the job.

New data highlight the long-lasting effects of the coronavirus, revealing changes that are not detectable by standard medical assessments. 

U.S.-China tariffs will have a $226M to $340M net impact on its bottom line in 2025, even after substantial mitigation efforts, the imaging manufacturer estimates. 
 

HeartMate 3 LVAD abbott

Researchers tracked short- and long-term data from nearly 2,000 patients, presenting their findings in JACC: Heart Failure

Cardiologist heart

Cardiologists are turning to leadless pacemakers more and more for cardiac pacing, but those devices have not previously been able to perform LBBAP. This new analysis includes new data on the world’s very first leadless LBBAP procedures. 

Around the web

“Dr. Saphier would be a catastrophic mistake on messaging and communicating with MAHA at a time where the coalition is very fragile,” one opponent says. 

The Erlangen, Germany-based device manufacturer announced its quarterly earnings results on May 7, which included a 6.5% year-over-year decline in revenue for its diagnostics segment. 

First approved by the FDA in 2021, providers have rapidly adopted this clinical innovation, which offers greater accuracy in detecting prostate cancer.